5385.0000 -194.00 (-3.48%)
NSE Jan 12, 2026 11:50 AM
Volume: 3,419
 

5385.00
-3.48%
IDBI Capital
EBITDA margin of 18.1% were higher than our estimates of 11.5%. Similarly, PAT of Rs317mn, +11.2% YoY, was higher than our estimates. We maintain our CY17E/18E estimates and TP (Rs1,179, 17x CY18E EPS+ CCE of Rs267/sh) and our rating of HOLD. Key Highlights and Investment Rationale India and other regions to fill the gap All players have seen the reversal patterns with the re-stocking happening in the channels which had got impacted during the last quarter due to the implementation...
Procter & Gamble Health Ltd.'s price crossed below 30Day SMA today
More from Procter & Gamble Health Ltd.
Recommended